Form 4: Disc Medicine Director Sells Shares
Insider Transaction (Form 4)
Kevin Bitterman, a Director of Disc Medicine, Inc., sold 54,496 shares of common stock on September 1, 2026.
Summary
- Open-market sale: disposed of 70 Common Stock at $79.95 ($5,596) on September 1, 2026; holds 349,140 after (Indirect).
- Open-market sale: disposed of 58 Common Stock at $79.95 ($4,637) on September 1, 2026; holds 337,427 after (Indirect).
- Open-market sale: disposed of 1 Common Stock at $79.95 ($80) on September 1, 2026; holds 14,012 after (Indirect).
- Open-market sale: disposed of 26,542 Common Stock at $80.17 ($2,127,872) on September 2, 2026; holds 322,598 after (Indirect).
- Open-market sale: disposed of 22,090 Common Stock at $80.17 ($1,770,955) on September 2, 2026; holds 315,337 after (Indirect).
- Open-market sale: disposed of 511 Common Stock at $80.17 ($40,967) on September 2, 2026; holds 13,501 after (Indirect).
- Open-market sale: disposed of 10 Common Stock at $80.98 ($810) on September 2, 2026; holds 322,588 after (Indirect).
- Open-market sale: disposed of 9 Common Stock at $80.98 ($729) on September 2, 2026; holds 315,328 after (Indirect).
- Open-market sale: disposed of 2 Common Stock at $80.98 ($162) on September 2, 2026; holds 13,499 after (Indirect).
- Open-market sale: disposed of 2,810 Common Stock at $79.98 ($224,744) on September 3, 2026; holds 319,778 after (Indirect).
- Open-market sale: disposed of 2,339 Common Stock at $79.98 ($187,073) on September 3, 2026; holds 312,989 after (Indirect).
- Open-market sale: disposed of 54 Common Stock at $79.98 ($4,319) on September 3, 2026; holds 13,445 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,367,944 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Kevin Bitterman — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Open-market sale | Common Stock | 70 | $80 | $5.6K | 349,140 |
| 2026-09-01 | Open-market sale | Common Stock | 58 | $80 | $4.6K | 337,427 |
| 2026-09-01 | Open-market sale | Common Stock | 1 | $80 | $80 | 14,012 |
| 2026-09-02 | Open-market sale | Common Stock | 26,542 | $80 | $2.1M | 322,598 |
| 2026-09-02 | Open-market sale | Common Stock | 22,090 | $80 | $1.8M | 315,337 |
| 2026-09-02 | Open-market sale | Common Stock | 511 | $80 | $41.0K | 13,501 |
| 2026-09-02 | Open-market sale | Common Stock | 10 | $81 | $810 | 322,588 |
| 2026-09-02 | Open-market sale | Common Stock | 9 | $81 | $729 | 315,328 |
| 2026-09-02 | Open-market sale | Common Stock | 2 | $81 | $162 | 13,499 |
| 2026-09-03 | Open-market sale | Common Stock | 2,810 | $80 | $224.7K | 319,778 |
| 2026-09-03 | Open-market sale | Common Stock | 2,339 | $80 | $187.1K | 312,989 |
| 2026-09-03 | Open-market sale | Common Stock | 54 | $80 | $4.3K | 13,445 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Open-market sale (70 shares) |
| 2026-09-01 | Open-market sale (58 shares) |
| 2026-09-01 | Open-market sale (1 shares) |
| 2026-09-02 | Open-market sale (26,542 shares) |
| 2026-09-02 | Open-market sale (22,090 shares) |
| 2026-09-02 | Open-market sale (511 shares) |
| 2026-09-02 | Open-market sale (10 shares) |
| 2026-09-02 | Open-market sale (9 shares) |
| 2026-09-02 | Open-market sale (2 shares) |
| 2026-09-03 | Open-market sale (2,810 shares) |
| 2026-09-03 | Open-market sale (2,339 shares) |
| 2026-09-03 | Open-market sale (54 shares) |
Keywords
insider transaction, Form 4, IRON, Disc Medicine, Inc., bearish, Kevin Bitterman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.